Mechanisms of disease: Ion channels - Basic science and clinical disease

New England Journal of Medicine

Volumn 336, Issue 22, 1997, Pages 1575-1586

  Ackerman, Michael J ^a,c   Clapham, David E ^b  

^a MAYO CLINIC   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Mayo Eugenio Litta Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; POTASSIUM CHANNEL; CELL SURFACE RECEPTOR; PURINE P2 RECEPTOR;

CYSTIC FIBROSIS; ELECTROPHYSIOLOGY; GENETIC DISORDER; ION TRANSPORT; LONG QT SYNDROME; MOLECULAR CLONING; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY;

CLONING, MOLECULAR; CYSTIC FIBROSIS; GTP-BINDING PROTEINS; HUMANS; ION CHANNELS; LONG QT SYNDROME; MUTATION; POTASSIUM CHANNELS; RECEPTORS, CELL SURFACE; RECEPTORS, PURINERGIC P2;

EID: 0031589944     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705293362207     Document Type: Review

References (67)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-56.
2. Keating MT. The long QT syndrome: a review of recent molecular genetic and physiologic discoveries. Medicine (Baltimore) 1996;75:1-5.
3. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994;79:407-14.
4. Snyder PM, Price MP, McDonald FJ, et al. Mechanism by which Liddie's syndrome mutations increase activity of a human epithelial Na+ channel. Cell 1995;83:969-78.
5. Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-9.
6. Dunne MJ, Kane C, Shepherd RM, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997;336:703-6.
7. Hudson AJ, Ebers GC, Bulman DE. The skeletal muscle sodium and chloride channel diseases. Brain 1995;118:547-63.
8. Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257: 797-800.
9. Ogawa Y. Role of ryanodine receptors. Crit Rev Biochem Mol Biol 1994;29:229-74.
10. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
11. Soreq H. The biosynthesis of biologically active proteins in mRNA-microinjected Xenopus oocytes. CRC Crit Rev Biochem 1985;18: 199-238.
12. Aiyar J, Withka JM, Rizzi JP, et al. Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron 1995;15:1169-81.
13. Catterall WA. Structure and function of voltage-sensitive ion channels. Science 1988;242:50-61.
14. Jan LY, Jan YN. Tracing the roots of ion channels. Cell 1992;69:7158.
15. Hoshi T, Zagotta WN, Aldrich RW. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 1990;250: 533-8.
16. Jan LY, Jan YN. Potassium channels and their evolving gates. Nature 1994;371:119-22.
17. Netter FH. Respiratory system. Ciba Collection Med Illustrations 1980;7:154.
18. Kommens JM, Iannuzzi MC, Kerem B-S, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245: 1059-65.
19. Riordan JR, Rommens JM, Kerem BS, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73. [Erratum, Science 1989;245:1437.]
20. Kerem B-S, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
21. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-9.
22. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis for most cystic fibrosis. Cell 1990;63:827-34.
23. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
24. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet 1994;93:364-8.
25. Gan K-H, Veeze HJ, van den Ouweland AMW, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995;333:95-9.
26. Anguiano A, Gates RD, Amos JA, et al. Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis. JAMA 1992; 267:1794-7
27. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-88.
28. Alton EW, Geddes DM. Gene therapy for cystic fibrosis: a clinical perspective. Gene Ther 1995;2:88-95.
29. Gribkoff VK, Champigny G, Barbry P, Dworetzky SI, Meanwell NA, Lazdunski M. The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel. J Biol Chem 1994;269:10983-6.
30. Howard M, Frizzel RA, Bedwell DM, Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 1996;2:467-9.
31. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996;271:635-8.
32. Voilley N, Lingueglia E, Champigny G, et al. The lung amiloride-sensitive Na+ channel: biophysical properties, pharmacology, ontogenesis, and molecular cloning, Proc Nat] Acad Sci U S A 1994;91:247-51.
33. Knowles MR, Olivier KN, Hohneker KW, Robinson J, Bennett WD, Boucher RC. Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis. Chest 1995;107:Suppl:71S-76S.
34. Knowles MR, Clarke LL, Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991;325:533-8.
35. Ackerman MJ, Clapham DE. Normal cardiac electrophysiology: understanding the action potential in the human heart. In: Chien K, ed. Molecular basis of heart disease: a companion to Braunwald's heart disease (in press).
36. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
37. Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke 1992; 1:309-14.
38. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J 1957;54:59-68.
39. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. Clin Pediatr 1963;45:656-83.
40. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964;54:103-6.
41. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23.
42. Ks cardiac potassium current. Nature 1996;384:78-80.
43. Ks potassium channel. Nature 1996;384:80-3.
44. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
45. Kr potassium channel. Cell 1995;81:299-307.
46. Smith PL, Baukrowitz T, Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 1996;379:833-6.
47. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80: 805-11.
48. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995;376:683-5.
49. Dumaine R, Wang Q, Keating MT, et al. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ Res 1996;78:916-24.
50. Schott J-J, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995;57:111422.
51. Compton SJ, Lux RL, Ramsey MR, et al. Genetically defined therapy of inherited long-QT syndrome: correction of abnormal repolarization by potassium. Circulation 1996;94:1018-22.
52. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 1995;92:3381-6.
53. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270: 1166-70.
54. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-6.
55. Terzic A, Jahangir A, Kurachi Y. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Am J Physiol 1995;269:C525-C545.
56. Ashcroft FM. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 1988;11:97-118.
57. Ashcroft SJ, Ashcroft FM. The sulfonylurea receptor. Biochim Biophys Acta 1992;1175:45-59.
58. Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996; 112:820-31.
59. Challinor-Rogers JL, McPherson GA. Potassium channel openers and other regulators of KATP channels. Clin Exp Pharmacol Physiol 1994;21: 583-97.
60. Haeusler G, Lues I. Therapeutic potential of potassium channel activators in coronary heart disease. Eur Heart J 1994;15:Suppl C:82-8.
61. Shen W-K, Kurachi Y. Mechanisms of adenosinc-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 1995;70: 274-91.
62. Pelleg A, Belardinelli L. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res 1993;27:54-61.
63. Malcolm AD, Garratt CJ, Camm AJ. The therapeutic and diagnostic cardiac electrophysiological uses of adenosine. Cardiovasc Drugs Ther 1993;7:139-47.
64. Wickman K, Clapham DE. Ion channel regulation by G proteins. Physiol Rev 1995;75:865-85.
65. KACh is a heteromultimer of two inwardly rectifying K+-channeI proteins. Nature 1995;374: 135-41.
66. KACh. J Biol Chem 1995;270: 29059-62.
67. βγ-insensitive weaver K+ channels. Science 1996;272:1950-3.